Skip to main content
Download PDF

Identification of partial trisomy 13q in two unrelated patients using single-nucleotide polymorphism array and literature overview

Molecular Cytogenetics volume 15, Article number: 31 (2022) Cite this article

Abstract

Background

Partial trisomy 13q is a less common chromosomal abnormality with a great clinical variability, among them, isolated partial trisomy 13q is extremely rare. Here, we report two new unrelated cases of partial trisomy 13q in Chinese families aiming to emphasize the genotype–phenotype correlation in partial trisomy 13q.

Methods

Enrolled in this study were two unrelated cases of partial 13q trisomy from two families in Quanzhou region South China. Karyotpe and single-nucleotide polymorphism (SNP) array analysis were employed to identify chromosome abnormalities and copy number variants in the families.

Results

A 72.9-Mb duplication in 13q14.11q34 region was identified using SNP array analysis in Patient 1 with an intellectual disability, developmental delay, seizures, gastric perforation, and other congenital malformations from a family with paternal inv(13)(p12q14.1). SNP array detection in Patient 2 revealed a 92.4-Mb duplication in 13q12.11q34 region combined with an 8.4-Mb deletion in Xq27.3q28 region with intellectual disability, developmental delay, cleft palate, and duplication of the cervix and the vagina. No chromosomal abnormality was elicited from the parents of Patient 2.

Conclusions

In this study, we presented two new unrelated cases of partial trisomy 13q with variable features in Chinese population, which may enrich the spectrum of the phenotypes partial trisomy 13q and further confirm the genotype–phenotype correlation.

Introduction

Trisomy 13, a common chromosomal disorder characterized by severe intellectual disability and life-threatening physical abnormalities, can be detected effectively during the prenatal period using non-invasive prenatal testing [1]. Partial trisomy 13q is a rare chromosomal abnormality with variable clinical phenotypes and distinctive clinical features similar with those in trisomy 13. Partial trisomy 13q most commonly results from parental balanced translocations or inversions, and rarely from de novo [2,3,4,5]. A distinct phenotype of partial proximal and partial distal trisomy of chromosome 13q has been defined [6]. Proximal trisomy 13q usually shows strabismus, low and flat nasal bridge, persistent foetal hemoglobin (Hb), and the increased number of nuclear projects on neutrophils and other congenital malformations. On the other hand, the distal trisomy 13q often presents features of polydactyl, hemangioma, bushy eyebrows, long eyelashes, long philtrum, thin upper lip, high arched palate, ocular aberrations, and other facial malformations [7, 8].

Deletion of Xq27.3q28 region is a rare chromosomal disorder typically characterized as developmental delay, intellectual disability, and characteristic facial features [9]. Male patients show more severe clinical features than females, which resemble as Hunter syndrome and Fragile X syndrome [10, 11]. However, female patients harboring Xq27.3q28 deletion demonstrate variable clinical manifestations [9, 12, 13].

In this study, we present two new unrelated cases of partial trisomy 13q with variable features in two Chinese families. The first case involved a patient who harbored an isolated duplication in 13q14.11-qter region. The other case was a girl who harbored a large duplication of 13q12.11-qter combined with Xq27.3q28 deletion.

Material and methods

Subjects

Two new unrelated cases of partial trisomy 13q with variable features in two Chinese families were enrolled in this study from Fujian province, South China. Both of their parents denied consanguineous marriage and any family history of inherited disease. Both families received pretest consultation and signed the written inform, subsequently, karyotype and chromosomal microarray analysis were preformed in the patients. Ethics Committee approval was obtained from the Institutional Ethics Committee of Quanzhou Women’s and Children’s Hospital to the commencement of the study (2020No.31).

Karyotype analysis

Approximately 2 ~  3 ml parental peripheral blood was collected from the patients and their parents for karyotype analysis. Around 20 ml amniotic fluid was obtained by amniocentesis for fetal chromosome karyotype analysis. The cultured amniotic fluid cells and peripheral blood lymphocytes were harvested using a SinochromeChromprepII automatic chromosome harvesting system according to the standard protocol (Shanghai Lechen Biotechnology Co., Ltd.) we described before [14]. Twenty metaphases were analyzed for peripheral blood karyotype and 30 metaphases were analyzed for fetal karyotype. Nomenclature of chromosomal karyotype was conducted according to ISCN 2020 [15].

DNA extraction

Approximately 3 ~ 5 ml peripheral bloods were collected from the patients and their parents for chromosomal microarray analysis. Approximately 10 ml amniotic fluid was obtained by amniocentesis for fetal chromosomal microarray analysis. Genomics DNA were extracted from peripheral blood using QIAamp DNA Blood Kit (QIAGEN, Germany) referred to the manufacturer’s protocol (www.qiagen.com).

SNP array detection

The single-nucleotide polymorphism array analysis was carried out using Affymetrix Cytoscan 750 K chip (Life Technologies, American) referred to the protocol described before [16]. The single-nucleotide polymorphism and copy number variants (CNVs) were analyzed using the Genotyping Console and Chromosome Analysis Suite software. The CNVs pathogenicity interpretation was conducted according to the American College of Medical Genetics (ACMG) standards and guidelines [17]. The Database of Genomic Variants (DGV) (http://dgv.tcag.ca/dgv), Online Mendelian Inheritance in Man (OMIM) (https://omim.org/), DECIPHER (https://deciphergenomics.org/) and PubMed (https: //www.ncbi.nlm.nih.gov/ pubmed/), as well as other databases, were used as reference resources.

Results

Patient 1

The proband in Family 1 was a girl who was the first child in this family. The patient was born full-term delivery with 50 cm (+ 0.18SD) in height and 2.45 kg ( − 2.3SD) in weight. The baby was found to have feeding difficulties and jaundice after birth. Her developmental milestone was dramatically delayed. She was unable to walk and speak until 4 years of age. A diagnosis of motor and language delay and intellectual disability was made. Gastric perforation occurred at the age of 5, for which surgical treatment was conducted. Then, seizures were observed at the age of 6, which could be controlled with antiepileptic drugs. Ultrasonography showed that the heart and kidneys were normal, but no brain MR image was available in this patient. At present, she is 8 years old, 118 cm ( − 2.0SD) tall and weighs 28 kg (+ 0.6SD), with no obvious facial dysmorphic features, except that her left ear is slightly smaller than the right one. She is now receiving compulsory education in the first grade of a primary school, which is one year behind the average children. She can read and write a little, with learning disability in arithmetic logic. In the 2nd pregnancy of Family 1, miscarriage occurred at the gestational age of 12+ weeks. At present, amniocentesis is carried out for prenatal diagnosis in the 3rd pregnancy of this family.

Patient 2

The proband 2 was also a girl born as the first child of Family 2. She was delivered at the gestational age of 37 weeks, with 50 cm (+ 0.18SD) in height and 3.0 kg ( − 0.6SD) in weight. The newborn had cleft palate and duplication of the cervix and vagina. Her developmental milestone was obviously delayed. At one year of age, she was able to sit independently, but presented vertical neck instability and could not turn over at the age of 1 year. In addition, no deciduous teeth were observed. The child's psychological assessment result showed that the total development quotient was 38. At the age of 1 year and one month, she was 73.8 cm ( − 0.9SD) tall, 7.6 kg ( − 2.3SD) in weight, and her head circumference was 44.2 cm ( − 0.7SD) without obvious facial deformity. She could not walk and speak at the age of 2 years. A diagnosis of motor and language developmental delay and intellectual disability was made. No brain MRI or ultrasound images of different organs were available. At present, amniocentesis is recommended and conducted for prenatal diagnosis in the 2nd pregnancy of Family 2.

Karyotype analysis results

Karyotype analysis in Patient 1 demonstrated a derivation of chromosome 13, which was described as 46,XX,rec(13)dup(13q)inv(13)(p12;q14.1)dpat (Additional file 1). Subsequent parental karyotype analysis showed that the mother’s karyotype was 46,XX and that of the father was 46,XY,inv(13)(p12;q14.1) (Fig. 1). In the 3rd pregnancy of family 1, karyotype analysis showed that the fetal karyotype was 46, X?,inv(13)(p12;q14.1).

Fig. 1
figure 1

Karyotype analysis result of the proband’s father in Family 1. The arrows indicate chromosomal aberration breakpoints. The karyotype of the proband’s father was 46,XY,inv(13)(p12;q14.1)

Full size image

The karyotype analysis in Patient 2 elicited an additional chromosomal material present on the long arm of chromosome X, and described as 46,XX,add(X)(q27.3) (Additional file 1). Both parents had a normal karyotype, indicating that the chromosomal abnormality in Patient 2 was a de novo structural variation. Subsequent prenatal diagnosis was carried out in the 2nd pregnancy of Family 2, showing a normal karyotype and no obvious ultrasound anomalies.

SNP array analysis results

SNP array analysis results showed a large 72.9-Mb fragment duplication (arr[GRCh37]13q14.11q34(42,195,553_115,107,733) × 3) (Fig. 2A) in 13q14.11q34 region in Patient 1, which contained 178 OMIM genes. According to the ACMG guidelines, partial trisomy 13q was interpreted as pathogenic. In addition, no copy number variant was observed in the parents or in the fetus of the 3rd pregnancy of the parents.

Fig. 2
figure 2

The SNP array results of Patient 1 and Patient 2. The arrows indicate chromosomal copy number variants. A A 72.9-Mb duplication in 13q14.11q34 region was detected in Patient 1. B A 92.4-Mb duplication in 13q12.11q34 region was observed in Patient 2. C A 8.4-Mb deletion in Xq27.3q28 region was also compounded in Patient 2

Full size image

SNP array analysis in Patient 2 showed a 92.4-Mb duplication in 13q12.11q34 region (arr[GRCh37]13q12.11q34(22,618,244_115,107,733) × 3) (Fig. 2B) associated with a 8.4-Mb deletion in Xq27.3q28 region (arr[GRCh37]Xq27.3q28(146,773,695_155,233,098) × 1) (Fig. 2C). Both variants were interpreted as pathogenic CNVs referred to ACMG guidelines. In addition, no copy number variant was observed in the fetus of the 2nd pregnancy of the parents.

Discussion

Partial trisomy 13q is a rare chromosomal abnormality with variable clinical phenotypes, with few cases of isolated partial trisomy 13q are available in the literature. In this study, we report two new unrelated cases of partial trisomy 13q in two Chinese families. In addition, we reviewed the clinical findings of isolated partial trisomy 13q in partial reported cases (Table 1), and found that most variants were inherited from the parental chromosome 13 inversions, and few of them were from direct parental inheritance or from de novo.

Table 1 Clinical findings in partial reported cases with isolated partial trisomy 13q
Full size table

At present, the genotype–phenotype correlation in partial trisomy 13q has not been fully understood. Partial trisomy 13q14qter is known with variable clinical features similar to trisomy 13. Previous studies have identified isolated trisomy 13q13qter in patients with intellectual disability and facial dysmorphism inherited from their mothers who carried a pericentric inversion of chromosome 13 [20, 26]. Some studies suggested that partial trisomy 13q11q13 may not contribute to most of the features of trisomy 13; in contrast, other studies suggested the region of 13q32qter as the main region causing the clinical features of trisomy 13 [27], which was further confirmed by the study that elicited a 13q32qter duplication in a patient with several abnormalities [4]. While, a mild clinical feature was observed in an 8-year-old male harboring 13q32qter duplication [28]. In addition, another study conducted by Krygier et al. [6] demonstrated a pure 13q31.1qter duplication in a patient presenting a relatively mild phenotype, suggesting that the critical region of trisomy 13 may be placed close to somewhere in the proximal region. In addition, a patient who carried the 13q14q31 duplication exhibited the clinical features including cleft lip/palate, low set ears, depressed nasal bridge, hypertelorism, and epicanthal fold [29]. In the present study, we report two unrelated cases with 13q14q34 duplication, presenting developmental delay, intellectual disability, and other congenital malformations, which are consistent with the previous studies.

As for 13q31.3q32.3 duplication, the GPC5 and GPC6 are indicated as candidate genes for polydactyl [30], while some other studies containing the genes showed the absence of polydactyly [18], suggesting incomplete penetrance in these variants. Similarly, both cases in our study covered the 13q31.3q32.3 region did not have polydactyl. Several studies have shown that patients with pure partial trisomy 13q had the clinical features of cleft lip and palate [23, 29], as well as the Patient 2 in our study shared the smallest region of 13q22q31, indicating that this region may be the critical region for cleft lip and palate phenotype. The duplication of 13q31.1qter was identified in patients with seizures in previous studies [6, 22], and presented in our study as well. Therefore, it is suggested that the distal 13q region may be responsible for seizures. In addition, haemangiomas has been reported to be associated with trisomy of 13q32qter [31], no feature of haemangiomas was observed in our case at present, while, we can not rule out the occurrence of haemangiomas in the further. At present, there are few case reports describing patients who carried 13q duplication and exhibited gastrointestinal abnormalities. However, a previous study elicited internal malrotation in a patient with tetrasomy 13q31qter [32], as well as the case presented in the DECIPHER database (ID:395,925) who harbored a 15.1-Mb duplication in 13q13.2q21 region. In this study, we observed an additional feature of gastric perforation in Patient 1, but whether this is ascribed to partial trisomy 13q needs more investigation.

Patient 2 in our report also presented Xq27.3q28 deletion, which was mainly represented by intellectual disability, developmental delay, and dysmorphic facial features [9]. A previous study indicated that most of unbalanced X;autosome translocations showed a skewed inactivation of der(X) chromosome [33], moreover, a report elicited a patient with mild clinical features who had der(X)t(X;13)(p21;q32), which may ascribe to inactivation of der(X) chromosome [34]. However, another study revealed a female with a karyotype of 46,X,der(X)t(X;4)(q22;q24) and showed that a high proportion (30%) of tested autosomal genes escaped inactivation, indicating that autosomal material lacking X chromosome specific features is associated with the spreading and/or maintenance of inactivation [35]. In this study, we can not rule out the effect of trisomy 13q that contribute to the clinical features of intellectual disability and developmental delay in Patient 2. In addition, previous studies presented urogenital anomalies including hypospadias, cryptorchidism and duplicated ureter in patients with partial trisomy 13q and partial tetrasomy [28, 32], and the feature of cleft palate as well [23, 29], but no report was available in the literature to clarify the relationship between Xq27.3q28 deletion and the clinical anomalies mentioned above. Thus, we believe the urogenital anomaly of the cervix and the vagina duplication, and cleft palate observed in Patient 2 may be ascribed to partial trisomy 13q. However, more work is needed to determine the genotype–phenotype relationship as shown in Patient 2.

In conclusion, partial trisomy 13q is a rare chromosomal abnormality, especially isolated partial trisomy 13q. In this study, we presented two new unrelated cases of partial trisomy 13q with variable features, exhibiting developmental delay, intellectual disability, and other congenital malformations, which were consistent with the previous studies. In comparison with other studies, we indicated that 13q22q31 region may be critical for cleft lip and palate phenotype and the distal region of 13q may be responsible for seizures. In addition, our study enriched the phenotype spectrum of partial trisomy 13q and further confirmed the genotype–phenotype correlations.

Availability of data and materials

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Ürel Demir G, Doğan ÖA, Şimşek Kiper PÖ, et al. Coexistence of trisomy 13 and SRY (-) XX ovotesticular disorder of sex development. Fetal Pediatr Pathol. 2017;36(6):445–51.

    Article  Google Scholar 

  2. Martin-de Saro M, Compean Z, Aguilar K, et al. Partial trisomy 13q/Monosomy 3p resulting from a paternal reciprocal 3p;13q translocation in a boy with facial dysmorphism and hypertrophic cardiomyopathy. Mol Syndromol. 2021;12(5):305–11.

    Article  CAS  Google Scholar 

  3. Du J, Tan YQ, Li LY, Lu GX. Molecular cytogenetic detection of partial chromosome 13q trisomy and its relation with the clinical features of tortilcollis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003;20(3):189–92.

    PubMed  Google Scholar 

  4. Rao VV, Carpenter NJ, Gucsavas M, Coldwell J, Say B. Partial trisomy 13q identified by sequential fluorescence in situ hybridization. Am J Med Genet. 1995;58(1):50–3.

    Article  CAS  Google Scholar 

  5. Patil SJ, Phadke SR. Pericentric inversion causing duplication and deletion of chromosome region 13q22 –> qter in the offspring. Am J Med Genet A. 2007;143A(1):82–4.

    Article  Google Scholar 

  6. Krygier M, Lipska-Zietkiewicz BS, Koczkowska M, Wierzba J, Limon J. Mild phenotype of a large partial 13q trisomy. Clin Dysmorphol. 2014;23(4):155–7.

    Article  Google Scholar 

  7. Xiao W, Gao Z, Meng Q, Zhang M. Cytogenetic and molecular genetic diagnosis of a neonate with partial 13q trisomy and partial 5p monosomy. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2014;31(6):747–9.

    PubMed  Google Scholar 

  8. Rogers JF. Clinical delineation of proximal and distal partial 13q trisomy. Clin Genet. 1984;25(3):221–9.

    Article  CAS  Google Scholar 

  9. Katoh K, Aiba K, Fukushi D, et al. Clinical and molecular genetic characterization of two female patients harboring the Xq27.3q28 deletion with different ratios of X chromosome inactivation. Hum Mutat. 2020;41(8):1447–60.

    Article  CAS  Google Scholar 

  10. Gecz J, Gedeon AK, Sutherland GR, Mulley JC. Identification of the gene FMR2, associated with FRAXE mental retardation. Nat Genet. 1996;13(1):105–8.

    Article  CAS  Google Scholar 

  11. Birot AM, Delobel B, Gronnier P, Bonnet V, Maire I, Bozon D. A 5-megabase familial deletion removes the IDS and FMR-1 genes in a male Hunter patient. Hum Mutat. 1996;7(3):266–8.

    Article  CAS  Google Scholar 

  12. Clarke JT, Wilson PJ, Morris CP, et al. Characterization of a deletion at Xq27-q28 associated with unbalanced inactivation of the nonmutant X chromosome. Am J Hum Genet. 1992;51(2):316–22.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Marshall LS, Simon J, Wood T, et al. Deletion Xq27.3q28 in female patient with global developmental delays and skewed X-inactivation. BMC Med Genet. 2013. https://doi.org/10.1186/1471-2350-14-49.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Zhuang J, Wang Y, Zeng S, Lv C, Lin Y, Jiang Y. A prenatal diagnosis and genetics study of five pedigrees in the Chinese population with Xp22.31 microduplication. Mol Cytogenet. 2019. https://doi.org/10.1186/s13039-019-0461-1.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Wang H. Introduction and interpretation of the updated contents of the international system for human cytogenomic nomenclature. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2021;38(12):1165–70.

    PubMed  Google Scholar 

  16. Zhuang J, Zhang N, Fu W, et al. Cytogenetic and molecular analysis of distal 4q duplication with distinctive phenotype using single-nucleotide polymorphism array. Mol Cytogenet. 2021;14(1):46.

    Article  CAS  Google Scholar 

  17. Kearney HM, Thorland EC, Brown KK, et al. American college of medical genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med. 2011;13(7):680–5.

    Article  Google Scholar 

  18. Atack E, Fairtlough H, Smith K, Balasubramanian M. A novel (paternally inherited) duplication 13q31.3q32.3 in a 12-year-old patient with facial dysmorphism and developmental delay. Mol Syndromol. 2014;5(5):245–50.

    Article  CAS  Google Scholar 

  19. Mathijssen IB, Hoovers JM, Mul AN, Man HY, Ket JL, Hennekam RC. Array comparative genomic hybridization analysis of a familial duplication of chromosome 13q: a recognizable syndrome. Am J Med Genet A. 2005;136(1):76–80.

    Article  Google Scholar 

  20. Mehra S, Christ L, Jeng L, Zinn AB, Schwartz S. Characterization of a familial balanced rec(13) in a child with mild MR and his half-sibling with two structurally rearranged chromosomes 13. Am J Med Genet A. 2005;137(2):217–21.

    Article  CAS  Google Scholar 

  21. Fraccaro M. De novo duplication 13q (46, XX, dup(13)(q21→q333)). Hum Genet. 1981;58(4):444.

    Article  CAS  Google Scholar 

  22. Habedank M. Familial pericentric inversion of chromosome 13 resulting in duplication 13q22 to qter. J Med Genet. 1982;19(3):227–9.

    Article  CAS  Google Scholar 

  23. Williamson EM, Miller JF, Seabright M. Pericentric inversion (13) with two different recombinants in the same family. J Med Genet. 1980;17(4):309–12.

    Article  CAS  Google Scholar 

  24. Machado IN, Heinrich JK, Campanhol C, Rodrigues-Peres RM, Oliveira FM, Barini R. Prenatal diagnosis of a partial trisomy 13q (q14–>qter): phenotype, cytogenetics and molecular characterization by spectral karyotyping and array comparative genomic hybridization. Genet Mol Res. 2010;9(1):441–8.

    Article  CAS  Google Scholar 

  25. Chen CP, Lin SP, Lee CC, Chen WL, Chen LF, Wang W. Perinatal findings of partial trisomy 13q (13q14.1–>qter) resulting from paternal pericentric inversion of chromosome 13. Prenat Diagn. 2005;25(6):527–8.

    Article  Google Scholar 

  26. Lucas J, Le Mée F, Picard F, Le Marec B, Junien C. Trisomie 13q13 leads to qter pure par recombinaison aneusomique d’une inversion péricentrique maternelle [Pure trisomy 13q13-qter caused by aneusomic recombination of a maternal pericentric inversion]. Ann Genet. 1983;26(3):187–90.

    CAS  PubMed  Google Scholar 

  27. Warburton PE, Dolled M, Mahmood R, et al. Molecular cytogenetic analysis of eight inversion duplications of human chromosome 13q that each contain a neocentromere. Am J Hum Genet. 2000;66(6):1794–806.

    Article  CAS  Google Scholar 

  28. Helali N, Iafolla AK, Kahler SG, Qumsiyeh MB. A case of duplication of 13q32–>qter and deletion of 18p11.32–>pter with mild phenotype: patau syndrome and duplications of 13q revisited. J Med Genet. 1996;33(7):600–2.

    Article  CAS  Google Scholar 

  29. Ou CY, Hsu TY, Chang JC, Chang SY. Partial trisomy 13 [46, XY, dup(13)(q14–31)]: a case report. Changgeng Yi Xue Za Zhi. 1998;21(1):82–5.

    CAS  PubMed  Google Scholar 

  30. van der Zwaag PA, Dijkhuizen T, Gerssen-Schoorl KB, et al. An interstitial duplication of chromosome 13q31.3q32.1 further delineates the critical region for postaxial polydactyly type A2. Eur J Med Genet. 2010;53(1):45–9.

    Article  Google Scholar 

  31. Gordon PL, Dalton JD, Martens PR, Tharapel AT, Wilroy RS. Elucidation of the centromere involvement in an inversion (13) by fluorescent in situ hybridisation. J Med Genet. 1993;30(5):414–6.

    Article  CAS  Google Scholar 

  32. Haddad V, Aboura A, Tosca L, et al. Tetrasomy 13q31.1qter due to an inverted duplicated neocentric marker chromosome in a fetus with multiple malformations. Am J Med Genet A. 2012;158A(4):894–900.

    Article  Google Scholar 

  33. Mattei MG, Mattei JF, Ayme S, Giraud F. X-autosome translocations: cytogenetic characteristics and their consequences. Hum Genet. 1982;61(4):295–309.

    Article  CAS  Google Scholar 

  34. Blennow E, Sahlén S. Rescue from the effects of trisomy 13q32–>qter owing to skewed X inactivation in a der(X)t(X;13)(p21;q32) carrier. J Med Genet. 1999;36(9):718–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. White WM, Willard HF, Van Dyke DL, Wolff DJ. The spreading of X inactivation into autosomal material of an x;autosome translocation: evidence for a difference between autosomal and X-chromosomal DNA. Am J Hum Genet. 1998;63(1):20–8.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We wish to express our appreciation to Fujian Provincial Health Commission for funding this work. We also express our appreciation to the patients who participated in this study.

Funding

This research was Sponsored by Fujian Provincial Health  Technology Project No. (2020QNB045).

Author information

Author notes

  1. Jianlong Zhuang and Chunnuan Chen have contributed equally to this work

Authors and Affiliations

  1. Prenatal Diagnosis Center, Quanzhou Women’s and Children’s Hospital, Quanzhou, People’s Republic of China

    Jianlong Zhuang, Wanyu Fu, Yanqing Li, Yuying Jiang, Shuhong Zeng & Xiaoxia Wu

  2. Department of Neurology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, Fujian Province, People’s Republic of China

    Chunnuan Chen

  3. Department of Gynecology, Quanzhou Women’s and Children’s Hospital, Quanzhou, People’s Republic of China

    Hegan Zhang

  4. Department of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of China

    Yingjun Xie

  5. Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of China

    Yingjun Xie

  6. Quanzhou Women’s and Children’s Hospital, Quanzhou, 362000, Fujian Province, People’s Republic of China

    Gaoxiong Wang

Authors
  1. Jianlong Zhuang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chunnuan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hegan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wanyu Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yanqing Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuying Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shuhong Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Xiaoxia Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yingjun Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Gaoxiong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JZ designed the study; JZ and CC wrote the article; HZ, YJ, WF and YL performed genetic consultation and recruited the participants; SZ performed routine chromosome analysis and data analysis; GW, YX, and XW modified and proofread the paper. All authors approved the final article.

Corresponding authors

Correspondence to Xiaoxia Wu, Yingjun Xie or Gaoxiong Wang.

Ethics declarations

Ethics approval and consent for participate

Ethics Committee approval was obtained from the Institutional Ethics Committee of Quanzhou Women’s and Children’s Hospital to the commencement of the study (2020No.31).

Consent for publication

We confirmed that all subjects participating in this study signed written informed consent for publication of their own and their children’s genetic data and relevant information.

Competing interests

The authors declare that they have no conflict of interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

Karyotype results of Patient 1 and Patient 2.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhuang, J., Chen, C., Zhang, H. et al. Identification of partial trisomy 13q in two unrelated patients using single-nucleotide polymorphism array and literature overview. Mol Cytogenet 15, 31 (2022). https://doi.org/10.1186/s13039-022-00608-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13039-022-00608-y

Keywords

  • Partial trisomy 13q
  • Karyotype analysis
  • SNP array
  • Seizures
  • Developmental delay

Molecular Cytogenetics

ISSN: 1755-8166